³ÉÈË¿ìÊÖ

This information is not held by Scottish Government.

The National Dental Inspection Programme (NDIP) is a key function of the Public Dental Service, delivery of which is the responsibility of Health Boards.

From the financial years 2020-21 to 2023-24, Scottish Government provided funding to Public Dental Services via Health Board allocations, however this did not specify funding for NDIP. From the financial year 2024-25, this funding has been baselined in to the overall Health Board allocation and is not separately identifiable.

Scottish Government regularly receives data from wellbeing services that support healthcare professionals. Each of the services actively gather user feedback which is shared with Scottish Government who use it to enhance and develop their wellbeing resources.

Scottish Government funding of over £2.5m has been committed to support the mental health and wellbeing of healthcare professionals in 2024-25. These resources include a 24/7 compassionate listening service, confidential treatment for mental illness through the Workforce Specialist Service and access to psychological therapies and interventions.

Prioritising these treatment and therapeutic programmes reflects our commitment to offer care and support to those staff suffering from burnout and mental illnesses.

In addition, the National Wellbeing Hub offers a range of self-care wellbeing enhancing resources and signposting to relevant mental health and support services. The content of The Hub is fully shaped by Health and Social Care (HSC) stakeholders, with a key focus on providing support and education on recognising and addressing burnout. It aims to help individuals identify burnout in themselves and others, offering practical interventions to prevent or mitigate its effects. These resources are designed both for individuals and those in supportive roles within teams, as well as guidance on accessing further support and recovery services.

It is recognised that more must be done to improve the working conditions of HSC staff to reduce the risk of burnout at its source.

Since March 2022, 16.8 whole time equivalent (WTE) posts have been in place. NHS Board partners provide quarterly reports on funding utilisation for Psychological Therapies for the Workforce.

In Quarter 3 of 2024-2025 (October 2024), the staff reported in post were 12.32 WTE, 0.8WTE in recruitment, 0.04WTE vacant.

The National Wellbeing Hub offers a range of self-service resources for staff across health, social care and social work on how to improve their wellbeing and resilience.

Less than 1% of the health budget was spent on the National Wellbeing Hub in financial years 2023-24 and 2024-25. The funding provided by Scottish Government is broken down as follows:

2023-24: £191,000 was allocated to the Hub.

2024-25: £96,000 was allocated to the Hub.

From 2024-25, Boards have started to transition to business as usual for these tests and a small amount of funding was provided to support this transition. For NHS Greater Glasgow and Clyde this equated to £36,450.

The Budget we set out on 4 December 2024 will throw the weight of the government behind performance improvements with almost £200 million to reduce waiting lists and help support reduction of delayed discharge. By March 2026, we expect no one to be waiting longer than 12 months for a new outpatient, inpatient treatment or day case treatment.

The Centre for Sustainable Delivery (CfSD) continues to support the roll out, and evaluation of the Oesophageal Cell Collection Device (CytoSponge) across Scotland.

However, whilst Scottish Ministers are responsible for determining the strategic policy of the NHS in Scotland, neither Scottish Ministers or officials are able to intervene directly in matters relating to clinical decision making as this is the sole responsibility of Healthcare professionals and Boards.

To specifically support scope based diagnostics we have published an backed by £70 million. The plan focuses on key areas such as: Balancing Demand and Capacity; Workforce Training and Development; Infrastructure; and Innovation and Redesign. This plan has delivered:

• Four mobile endoscopy units across Scotland, providing 5-6 additional endoscopy rooms.
• A national endoscopy surveillance framework, introduced in February 2022, which has been implemented in all Health Boards and holds near-real time information for patients in Scotland having regular endoscopy checks (surveillance).
• Triage tools such as qFIT, and endoscopy alternatives such as Cytosponge, and Colon Capsule Endoscopy have also been introduced.

As part of the Scottish Government’s Endoscopy Recovery and Remobilisation Plan (2021) nurse led Oesophageal Cell Collection Device services were rolled out across NHS Boards. To date, 11 Mainland Boards have active services with over 6,000 procedures delivered to August 2023. The OesophagealCell Collection Device is an alternative to endoscopy for diagnosis of pre and early oesophageal cancer as part of Upper GI Endoscopy Recovery Planning. The Centre for Sustainable Delivery (CfSD) continue to support the roll out, and evaluation of OesophagealCell Collection Device across Scotland.

Since starting in September 2020, NHS Greater Glasgow & Clyde have performed 1,680 oesophageal sponge cytology tests.

The Scottish Government is aware of the Spanish Tax Lease system.

The management of the Police Scotland Estate is an operational matter, and is the responsibility of the Chief Constable under the scrutiny of the Scottish Police Authority.

Police Scotland is considering the future of both the Possilpark (Saracen) Police station and their former police station in Springburn. Police Scotland consults widely on its plans for public facing properties, including disposal, in advance of any decisions being made.

Scotland’s screening policy relies on recommendations from the UK National Screening Committee (UK NSC), an independent scientific body that provides advice on screening policy to all four UK nations. To date, the UK NSC has not recommended Spinal Muscular Atrophy (SMA) screening through the existing newborn blood spot test, and has stated it requires further evidence before a decision can be made.

The UK NSC continues to monitor and review the rapidly developing evidence base regarding SMA screening. Most recently, in November 2024, the into SMA screening for the UK context were presented at a workshop to stakeholders. The findings of this study, in conjunction with the proposed In Service Evaluation of SMA screening in some areas of England, will inform the UK NSC’s considerations regarding whether SMA screening should be recommended.

The UK NSC updates on significant developments regarding potential and existing screening programmes on their blog. This can be found at